The appearance of aggregated erythrocytes in the peripheral blood of individuals with insulin resistance

Diabetes/Metabolism Research and Reviews

Volumn 19, Issue 5, 2003, Pages 386-391

  Justo, Daniel ^a   Marilus, Rafael ^a   Mardi, Tamar ^a   Tolchinsky, Tatiana ^a   Goldin, Yelena ^a   Rozenblat, Meirav ^a   Rogowski, Ori ^a   Yerushalmi, Yair ^a   Stern, Naftali ^a   Shenkerman, Galina ^a   Deutsch, Varda ^a   Zeltser, David ^a   Berliner, Shlomo ^a   Shapira, Itzhak ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acute phase response; Adhesiveness aggregation; Erythrocyte; Insulin resistance

Indexed keywords

FIBRINOGEN; GLUCOSE; PLASMA PROTEIN;

ACUTE PHASE RESPONSE; ARTICLE; BLOOD; BLOOD RHEOLOGY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE AGGREGATION; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROBABILITY; THROMBOGENICITY;

ERYTHROCYTE AGGREGATION; HUMANS; INFLAMMATION; INSULIN RESISTANCE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 12444340882     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.391     Document Type: Article

References (52)

1. Festa A, D'Argostino RB, Howard G, Mykkanen L, Tracy RP, Haffner SM. The Insulin Resistance Atherosclerosis Study (IRAS). Chronic subclinical inflammation as part of the insulin resistance syndrome. Circulation 2000; 104: 42-47.
2. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-2135.
3. Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes 2001; 50: 2384-2389.
4. Vazarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA. High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002; 51: 455-461.
5. Chambers JC, Eda S, Basset P, et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from United Kingdom compared with European whites. Circulation 2001; 104: 145-150.
6. Pradhan AD, Madson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin, 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334.
7. Yudkin JS, Stehouwer CDA, Coppack SW. C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972-978.
8. Ridker PM. On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. Circulation 2002; 105: 2-4.
9. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143.
10. MacRury SM, Lowe GDO. Blood rheology and diabetes mellitus. Diabet Med 1990; 7: 285-291.
11. Caimi G, Canino B, Romano A, Catania A, Presti L. Erythrocyte aggregation and erythrocyte membrane properties in type 2 diabetes mellitus and in vascular atherosclerotic disease. Thromb Haemost 2000; 83: 516-517.
12. Caimi G, Lo PR, Montana M, et al. Diabetes mellitus: mean erythrocyte aggregation, glycometabolic pattern, red cell Ca2+ content, and erythrocyte membrane dynamic properties. Microvasc Res 1993; 46: 401-405.
13. 2-permeable tube: effects of erythrocyte aggregation. Am J Physiol Heart Circ Physiol 2001; 281: H448-H456.
14. Klingel R, Fassbender C, Fassbender T, Erdtracht B, Berrouschot J. Rheopheresis: rheologic, functional and structural aspects. Ther Apheresis 2000; 4: 348-357.
15. Lowe G, Rumley A, Norrie J, et al. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland coronary prevention study. Thromb Haemost 2000; 84: 553-558.
16. El Bouhmadi A, Laffargue F, Raspal N, Brun JF. 100 mg acetylsalicylic acid acutely decreases red cell aggregation in women taking oral contraceptives. Clin Hemorheol Microcirc 2000; 22: 99-106.
17. Orringer EP, Casella JF, Ataga KI, et al. Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: a randomized controlled trial. JAMA 2001; 286: 2152-2153.
18. Dujovne CA, Harris WS, Altman R, Overhiser RW, Black DM. Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients. Am J Cardiol 2000; 85: 350-353.
19. International Committee for Standardization in Hematology. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 1965; 2: 235-254.
20. Clauss A. Gerinnungsphysiologische Shnellmethode zur Bestimmung des Fibrinogens. Acta Haematol Basel 1957; 17: 237-246.
21. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999; 45: 2136-2141.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in men. Diabetologia 1985; 28: 412-419.
23. Rotstein R, Fusman R, Berliner S, et al. The feasibility of estimating the erythrocyte sedimentation rate within a few minutes by using a simple slide test. Clin Lab Haematol 2001; 23: 21-25.
24. Gamzu R, Rotstein R, Fusman R, Zeltser D, Berliner AS, Kupferminc MJ. Increased erythrocyte adhesiveness and aggregation in peripheral venous blood of women with pregnancy-induced hypertension. Obstet Gynecol 2001; 98: 307-312.
25. Rotstein R, Fusman R, Zeltser D, et al. The picture of inflammation: a new concept that combines the white blood cell count and erythrocyte sedimentation rate into a new hematologic diagnostic modality. Acta Haematol 2001; 106: 106-114.
26. Sharshun Y, Brill S, Mardi T, et al. inflammation at a glance. The erythrocyte adhesiveness/aggregation to reveal the presence of inflammation in individuals with atherothrombosis. Heart Dis 2003; 5: 182-183.
27. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
28. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 11: 448-454.
29. Weng X, Roederer GO, Beaulieu R, Cloutier G. Contribution of acute-phase proteins and cardiovascular risk factors to erythrocyte aggregation in normolipidemic and hyperlipidemic individuals. Thromb Haemost 1998; 80: 903-908.
30. Weng X, Cloutier G, Beaulieu R, Roederer GO. Influence of acute-phase proteins on erythrocyte aggregation. Am J Physiol 1996; 271: H2346-H2352.
31. Talstad I, Scheie P, Dalen H, Roli J. Influence of plasma proteins on erythrocyte morphology and sedimentation. Scand J Haematol 1983; 31: 478-484.
32. Talstad I, Haugen HF. The relationship between the erythrocyte sedimentation rate (ESR) and plasma proteins in clinical materials and models. Scand J Clin Lab Invest 1979; 39: 519-524.
33. Ernst E, Weihmayr T, Matrai A, Resch KL. Changes in blood rheology of grossly obese individuals during a very low calorie diet. Int J Obes 1989; 13 (Suppl. 2): 167-168.
34. Fanari P, Somazzi R, Nasrawi F, et al. Haemorheological changes in obese adolescents after short-term diet. Int J Obes Relat Metab Disord 1993; 17: 487-494.
35. Poggi M, Palareti G, Biagi R, et al. Prolonged very low calorie diet in highly obese subjects reduces plasma viscosity and red cell aggregation but not fibrinogen. Int J Obes Relat Metab Disord 1994; 18: 490-496.
36. Valensi P, Paries J, Maheo P, Gaudey F, Attali JR. Erythrocyte rheological changes in obese patients: influence of hyperinsulinism. Int J Obes Relat Metab Disord 1996; 20: 814-819.
37. Valensi P, Smagghue O, Paries J, Velayoudon P, Lormeau B, Attali JR. Impairment of skin vasoconstrictive response to sympathetic activation in obese patients: influence of rheological disorders. Metabolism 2000; 49: 600-606.
38. Caimi G, Lo Presti R, Serra A, et al. Rheological determinants and red cell lipidic pattern in essential obesity, in obese subjects with non-insulin-dependent diabetes mellitus (NIDDM) and in obese subjects with glucose tolerance (IGT). Microcirc Endothelium Lymphatics 1991; 7: 293-304.
39. Mchedlishvili G, Gobejishvili L, Mamaladze A, Momtselidze N, Varazashvili M. Microcirculatory stasis induced by hemorheological disorders: further evidence. Microcirculation 1999; 6: 97-106.
40. Koenig W, Sund M, Filipiak B, Doring A, Lowel H, Ernst E. Plasma viscosity and the risk of coronary heart disease results from the MONICA-Ausburg cohort study, 1984-1992. Arterioscler Thromb Vasc Biol 1998; 18: 768-772.
41. Ben Ami R, Barshtein G, Zeltser D, et al. Parameters of red blood cell aggregation as correlates of the inflammatory state. Am J Physiol Heart Circ Physiol 2001; 280: H1982-H1988.
42. Fusman R, Zeltser D, Rotstein R, et al. INFLAMET: an image analyzer to display erythrocyte adhesiveness/aggregation. Eur J Int Med 2000; 11: 271-276.
43. Rogowski O, Zeltser D, Rotstein R, et al. Correlated expression of adhesive properties for both white and red blood cells during inflammation. Biorheology 2000; 37: 361-370.
44. Hershcovici T, Elishkewitch K, Rotstein R, et al. The erythrocyte adhesiveness/aggregation test to reveal real-time information of rheological relevance in patients with familial and primary hypercholesterolemia before and following plasma exchange. Ther Apheresis 2002; 6: 140-144.
45. Cabel M, Meiselman HJ, Popel AS, Johnson PC. Contribution of red blood cell aggregation to venous vascular resistance in skeletal muscle. Am J Physiol 1997; 272: H1020-H1032.
46. Fisher M, Meiselman HJ. Hemorheological factors in cerebral ischemia. Stroke 1991; 22: 1164-1169.
47. Rotstein R, Landau T, Twig A, et al. The erythrocyte adhesiveness/aggregation test (EAAT). A new biomarker to reveal the low grade subclinical smoldering inflammation individuals with atherosclerotic risk factors. Atherosclerosis 2002; 165: 343-351.
48. Tchernof A, Nolan A, Sitaes CK, Ades PA, Poehlman ET. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 2002; 105: 564-569.
49. Ziccardi F, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804-809.
50. Abramson JL, Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults. Arch Intern Med 2002; 162: 1286-1292.
51. Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase enzyme. Arterioscler Thromb Vasc Biol 2002; 21: 1712-1719.
52. Miossec P, Zkhiri F, Paries J, David-Dufilho M, Devynck MA, Valensi PE. Effect of pravastatin on erythrocyte rheological and biochemical properties in poorly controlled type 2 diabetic patients. Diabet Med 1999; 16: 424-430.